Normalization of Soluble CD163 Levels After Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological Abnormalities

BACKGROUND: Myeloid activation contributes to cognitive impairment in chronic human immunodeficiency virus (HIV) infection. We explored whether combination antiretroviral therapy (cART) initiation during acute HIV infection impacts CD163 shedding, a myeloid activation marker, and in turn, implicatio...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Infect Dis
Auteurs principaux: D’Antoni, Michelle L, Byron, Mary Margaret, Chan, Phillip, Sailasuta, Napapon, Sacdalan, Carlo, Sithinamsuwan, Pasiri, Tipsuk, Somporn, Pinyakorn, Suteeraporn, Kroon, Eugene, Slike, Bonnie M, Krebs, Shelly J, Khadka, Vedbar S, Chalermchai, Thep, Kallianpur, Kalpana J, Robb, Merlin, Spudich, Serena, Valcour, Victor, Ananworanich, Jintanat, Ndhlovu, Lishomwa C
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2018
Sujets:
Major Articles and Brief Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6151077/
https://ncbi.nlm.nih.gov/pubmed/29868826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy337
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires